[go: up one dir, main page]

UY30413A1 - Moléculas duales que contienen un derivado peroxidico, su sintesis y sus aplicaciones terapéuticas. - Google Patents

Moléculas duales que contienen un derivado peroxidico, su sintesis y sus aplicaciones terapéuticas.

Info

Publication number
UY30413A1
UY30413A1 UY30413A UY30413A UY30413A1 UY 30413 A1 UY30413 A1 UY 30413A1 UY 30413 A UY30413 A UY 30413A UY 30413 A UY30413 A UY 30413A UY 30413 A1 UY30413 A1 UY 30413A1
Authority
UY
Uruguay
Prior art keywords
synthesis
therapeutic applications
molecules containing
derivative
dual molecules
Prior art date
Application number
UY30413A
Other languages
English (en)
Inventor
Pellet Alain
Meunier Bernard
Cosledan Frederic
Original Assignee
Centre Nat Rech Scient
Palumed
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37719816&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30413(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centre Nat Rech Scient, Palumed, Sanofi Aventis filed Critical Centre Nat Rech Scient
Publication of UY30413A1 publication Critical patent/UY30413A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La invencion se refiere a las moléculas duales híbridas que contienen un derivado peroxídico, que tienen especialmente una actividad antipaludica y que responden a la formula I, en el estado de base o de sal de adicion a un ácido, en el estado de hidrato o de solvato, en forma racémica, isomeros y sus mezclas, así como sus diastereoisomeros y sus mezclas. Se describen también los procedimientos de preparacion y las aplicaciones como medicamentos.
UY30413A 2006-06-13 2007-06-13 Moléculas duales que contienen un derivado peroxidico, su sintesis y sus aplicaciones terapéuticas. UY30413A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0605235A FR2902100A1 (fr) 2006-06-13 2006-06-13 Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique

Publications (1)

Publication Number Publication Date
UY30413A1 true UY30413A1 (es) 2008-01-31

Family

ID=37719816

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30413A UY30413A1 (es) 2006-06-13 2007-06-13 Moléculas duales que contienen un derivado peroxidico, su sintesis y sus aplicaciones terapéuticas.

Country Status (24)

Country Link
US (1) US20120122923A1 (es)
EP (1) EP2032561A2 (es)
JP (1) JP2009539946A (es)
KR (1) KR20090029208A (es)
CN (1) CN101466706A (es)
AP (1) AP2008004711A0 (es)
AR (1) AR061347A1 (es)
AU (1) AU2007259116A1 (es)
BR (1) BRPI0713739A2 (es)
CA (1) CA2665940A1 (es)
CR (1) CR10469A (es)
EA (1) EA200970002A1 (es)
EC (1) ECSP088958A (es)
FR (1) FR2902100A1 (es)
IL (1) IL195394A0 (es)
MA (1) MA30577B1 (es)
MX (1) MX2008015980A (es)
NO (1) NO20085308L (es)
PE (1) PE20080335A1 (es)
TN (1) TNSN08462A1 (es)
TW (1) TW200817376A (es)
UY (1) UY30413A1 (es)
WO (1) WO2007144487A2 (es)
ZA (1) ZA200810012B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2924343A1 (fr) * 2007-12-04 2009-06-05 Palumed Sa Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique.
CN103857288B (zh) 2011-03-04 2016-09-21 葛兰素史密斯克莱知识产权发展有限公司 作为激酶抑制剂的氨基-喹啉
TWI547494B (zh) 2011-08-18 2016-09-01 葛蘭素史克智慧財產發展有限公司 作為激酶抑制劑之胺基喹唑啉類
AR092529A1 (es) 2012-09-13 2015-04-22 Glaxosmithkline Llc Compuesto de aminoquinazolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento
AR092530A1 (es) 2012-09-13 2015-04-22 Glaxosmithkline Llc Compuesto de amino-quinolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento
EP2958911B1 (en) 2013-02-21 2017-10-18 GlaxoSmithKline Intellectual Property Development Limited Quinazolines as kinase inhibitors
CN119822967A (zh) * 2024-12-24 2025-04-15 万华化学集团股份有限公司 一种hmda的生产方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2133620A1 (en) * 1993-10-28 1995-04-29 Werner Hofheinz Aminoquinoline derivatives
TR199800854T2 (xx) * 1995-11-16 1998-08-21 F.Hoffmann-La Roche Ag Antis�tma kinolin t�revleri.
JP2002513005A (ja) * 1998-04-29 2002-05-08 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Ｍｒｓ阻害剤および殺菌剤用のキノロン類
FR2807433B1 (fr) * 2000-04-06 2002-09-20 Centre Nat Rech Scient Molecules duales contenant un derives peroxydique, leur synthese et leurs applications therapeutiques
US6486199B1 (en) * 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
WO2003070244A1 (en) * 2002-02-22 2003-08-28 Abbott Laboratories Antagonist of melanin concentrating hormone and their uses
SE0202134D0 (sv) * 2002-07-08 2002-07-08 Astrazeneca Ab Therapeutic agents
BR0313743A (pt) * 2002-08-23 2005-07-05 Chiron Corp Benzimidazol quinolinonas e usos destas
US20050256157A1 (en) * 2002-08-23 2005-11-17 Chiron Corporation Combination therapy with CHK1 inhibitors
US20050197350A1 (en) * 2003-03-31 2005-09-08 Taisho Pharmaceutical Co., Ltd. Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
HU227684B1 (en) * 2003-08-29 2011-11-28 Sanofi Aventis Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
FR2862304A1 (fr) * 2003-11-14 2005-05-20 Centre Nat Rech Scient Molecules duales racemiques ou achirales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques
JP2007517868A (ja) * 2004-01-07 2007-07-05 アストラゼネカ アクチボラグ 治療薬ｉ
US7884207B2 (en) * 2004-06-18 2011-02-08 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
FR2889525A1 (fr) * 2005-08-04 2007-02-09 Palumed Sa Nouveaux derives de polyquinoleines et leur utilisation therapeutique.

Also Published As

Publication number Publication date
EA200970002A1 (ru) 2009-06-30
AP2008004711A0 (en) 2008-12-31
TW200817376A (en) 2008-04-16
WO2007144487A2 (fr) 2007-12-21
CR10469A (es) 2009-02-26
JP2009539946A (ja) 2009-11-19
IL195394A0 (en) 2009-08-03
AR061347A1 (es) 2008-08-20
FR2902100A1 (fr) 2007-12-14
US20120122923A1 (en) 2012-05-17
ZA200810012B (en) 2010-05-26
EP2032561A2 (fr) 2009-03-11
WO2007144487A3 (fr) 2008-02-07
TNSN08462A1 (en) 2010-04-14
CA2665940A1 (fr) 2007-12-21
ECSP088958A (es) 2009-01-30
AU2007259116A8 (en) 2009-04-30
BRPI0713739A2 (pt) 2013-06-18
MA30577B1 (fr) 2009-07-01
PE20080335A1 (es) 2008-05-22
AU2007259116A1 (en) 2007-12-21
NO20085308L (no) 2009-03-12
KR20090029208A (ko) 2009-03-20
CN101466706A (zh) 2009-06-24
MX2008015980A (es) 2009-03-26

Similar Documents

Publication Publication Date Title
UY28955A1 (es) Nuevos derivados fluoroglicosídicos de pirazoles, medicamentos que contienen estos compuestos, y el empleo de los mismos
UY30500A1 (es) Compuestos de azabencimidazolilo
CU20090184A7 (es) Compuestos amino-heterocíclicos
CY1115199T1 (el) Κυτταροτοξικοι παραγοντες που περιεχουν νεα παραγωγα τομαϋμυκινης και η θεραπευτικη τους χρηση
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
CR10027A (es) Nuevos derivados de pirrol fusionado
UY30804A1 (es) Derivados de nicotinamida, sus sales y solvatos, composiciones farmacéuticas conteniendolas y aplicaciones
PA8592201A1 (es) Nuevos derivados de fluoroglicosidos aromaticos, medicamentos que contienen estos compuestos y sus usos
CO6361936A2 (es) Imidazopiridazinacarbonitrilos utiles como inhibidores de quinasa
UY34974A (es) Piridazina 1,4 disustituida, análogos de la misma y métodos para tratar las enfermedades relacionadas con deficiencia del smn
UY30413A1 (es) Moléculas duales que contienen un derivado peroxidico, su sintesis y sus aplicaciones terapéuticas.
PA8592301A1 (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
CR10479A (es) Modulares bencimidazolicos de vr1
ECSP088747A (es) Pirazoles como inhibidores de la 11-beta-hsd1
UY31189A1 (es) Compuestos heterocíclicos
CO6480931A2 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas.
UY30282A1 (es) Compuestos quimicos
CR20110219A (es) Ácidos naftilacéticos
UY30220A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
ECSP088689A (es) NOVEDOSAS 11ß-HIDROXIANDROSTA-4-EN-3-ONAS
UY30476A1 (es) Noveles compuestos derivados n-sustituidos de la 3-oxoisoindolin-1-carboxamida, sus sales aceptables, composiciones farmaccuticas y aplicaciones.
AR076686A1 (es) Compuesto anticancerigeno y composicion farmaceutica que lo contiene
CY1116840T1 (el) Χρηση 24-norudca
CY1113240T1 (el) Αλατα ενωσεων αναστολεα hiv

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20130226